Consider a patient on postoperative day eight after a total knee replacement. She is 68 years old, managing her pain at home, and has already missed two doses of her anticoagulant because of nausea. Her calf is swollen. There is new redness around the wound. Her first follow-up appointment is three weeks away.
Her outcome will depend almost entirely on what happens in the next 24 hours. Not on what happened in the operating room.
This is the clinical reality CMS just formally acknowledged. Last month the agency announced the expansion of the Comprehensive Care for Joint Replacement model into a mandatory, nationwide program beginning October 2027. Under CJR-X, hospitals will be held financially accountable for the total cost of care across the full 90-day episode following hip, knee, and ankle replacement surgery. Not just the procedure. Not just the hospital stay. The entire recovery period, including every readmission, every emergency visit, and every complication that occurs after the patient walks out the door.
It is one of the most significant amendments in surgical accountability in a decade. And most health systems are not structurally equipped to meet it.
The Numbers Behind the Policy
The scale of what CMS is responding to is significant. Approximately 1.3 million total hip and knee replacements are performed annually in the United States. The 30-day readmission rate following total joint arthroplasty runs at approximately 4.2 percent, with surgical site infection, wound complications, and venous thromboembolism as the leading causes. Nearly half of all unplanned readmissions occur within the first 30 days of discharge, the same window when most patients have no scheduled clinical contact whatsoever.
Standard protocol at most institutions schedules the first postoperative follow-up between three and six weeks after discharge. The highest-risk period is the least monitored.
The financial consequences are real and growing. The original CJR pilot, which ran from 2016 through 2024, generated significant Medicare savings while maintaining quality of care. MedPAC analysis estimated that readmission reductions under the Hospital Readmissions Reduction Program produce savings of approximately $2 billion annually. CJR-X takes that accountability mandate and makes it mandatory and national, effective October 2027.
What Goes Wrong at Home
The complications most likely to drive a readmission after joint replacement are well characterized. Wound infection and dehiscence in the first ten days. DVT and pulmonary embolism risk from missed anticoagulation in the seven to fourteen day window. Pain mismanagement and functional decline in the first two to four weeks. Medication errors throughout.
Approximately 20 percent of patients experience an adverse event after hospital discharge. Roughly two-thirds of those events are either preventable or mitigatable with earlier clinical intervention. For patients on postoperative anticoagulation, a missed dose or unrecognized drug interaction can result in both thrombotic and hemorrhagic complications during the highest-risk recovery window.
When patients cannot reach their care team, they act on whatever information they can find. Consumer AI tools and unvalidated online sources are increasingly filling that gap, with results that are often inaccurate, incomplete, or clinically inappropriate for a specific postoperative course.
Care teams are stretched. Transition workflows are inconsistent across service lines. The burden of self-management falls on patients at the exact moment they are least equipped to carry it, immediately post-surgery, managing pain, new medications, adjusting to activity restrictions, and monitoring their own healing without structured clinical support.
The Infrastructure Gap CJR-X Exposes
The current healthcare system was built around the procedure. Surgical teams are optimized for what happens in the operating room. Perioperative protocols have advanced substantially. What the system was not built to support is the two weeks that follow discharge, when complications emerge and outcomes diverge.
Health systems participating in bundled payment models have begun adapting, extending clinical oversight into the recovery period with structured remote monitoring and patient-initiated access. The challenge is doing this at scale, across high volumes of joint replacement patients, with consistent protocols and reliable escalation pathways.
CJR-X makes this adaptation mandatory. Beginning October 2027, most hospitals will be required to participate, making it the first mandatory, nationwide episode-based payment model in CMS history. The financial accountability that hospitals managed voluntarily under the original CJR pilot becomes the baseline expectation for the entire system.
What Effective Post-Discharge Care Requires
The clinical priorities during the recovery window are well-defined. Wound surveillance for signs of infection or dehiscence. Anticoagulation adherence monitoring and VTE symptom assessment. Pain management and early identification of inadequately controlled pain limiting functional recovery. Medication reconciliation across the full postoperative course.
Meeting these priorities requires continuous clinical access, intelligent triage, and proactive outreach. It requires structured communication between the surgical team and post-acute care providers and a defined pathway for patients to reach clinical support before a complication escalates into a readmission.
This is where Dimer Health operates. Selected by CMS as an ACCESS participant, Dimer Health was built specifically to address the critical patient-care gap that exists during the post-discharge period. During the most vulnerable weeks of recovery, Dimer’s AI clinical teammate AiME supports patients through that vital 90-day window. Grounded in the patient’s full medical record history and backed by a physician-led resource team, AiME knows what medications they are on, when the next follow-up visit is scheduled, and catches warning signals before symptoms escalate to a health emergency. Dimer Health is already deployed inside Atlantic Health System and Bergen New Bridge Medical Center in New Jersey, and Emblem Health in New York. In practice, 50 percent of patients who received an escalation recommendation through AiME connected with a clinician, the exact intervention that converts an early warning into a prevented readmission.
The Question Every Program Needs to Answer
CJR-X becomes mandatory in October 2027. That gives orthopedic programs roughly 18 months to build infrastructure for a phase of care that the current system treats as a gap.
The question for every orthopedic program, whether currently in bundled payment models or anticipating future participation, is direct. Does your program have the capability to monitor patients during the two weeks after discharge, when complications are most likely to emerge? Do your patients have a way to reach a clinician between discharge and their first follow-up appointment? Do your care teams have real-time visibility into what is happening at home?
The programs that can answer those questions affirmatively will be better positioned to reduce readmissions, protect bundled payment performance, and deliver the standard of post-operative care that CMS policy and patients increasingly expect.
The future of surgical care follows the patient home. The accountability framework is already in place. The window to build the infrastructure to meet it is now.
Dr. David L. Feldman
Dr. David Feldman is Chief Medical Officer at Dimer Health. Selected by CMS as an ACCESS participant, Dimer Health was built to address the critical patient-care gap during the post-discharge period. Dimer's AI clinical teammate AiME supports patients through the vital 90-day recovery window, backed by the patient's full medical record history and a physician-led resource team. Dimer Health is deployed inside Atlantic Health System, Emblem Health and Bergen New Bridge Medical Center in New Jersey.
